You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Claims for Patent: 11,793,766


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,793,766
Title:Non-aqueous patch for the relief of pain
Abstract:[Problem] If lidocaine is composed of non-aqueous patch, the adhesive power of the preparation tends to get lower, as the composition amount of lidocaine is higher. It is popular to solve lidocaine in dissolving agent in order to compose lidocaine in patch and release effective amount into skin. However, if the amount of dissolving agent gets higher, the adhesive power gets extremely lower, so that an long-time attachment is difficult.[Solution]A non-aqueous patch comprising lidocaine and/or its reactant, and a dissolving agent which are contained in a base of plaster, the plaster being hold by a support, of which strength of 50% stretched to longitudinal direction is less than 2000 g/50 mm and of biaxially-oriented stretch cloth.
Inventor(s):Tatsuya Mori, Naoyuki Saida
Assignee: Oishi Koseido Co Ltd , Itochu Chemical Frontier Corp
Application Number:US16/941,413
Patent Claims: 1. A method of relieving pain in an individual in need thereof, comprising applying a non-aqueous patch to the skin of the individual in need thereof, wherein the non-aqueous patch comprises 0.5 to 7 mass % lidocaine, and a dissolving agent comprising an organic acid and a polyalcohol, wherein the lidocaine and the dissolving agent are in a plaster, the plaster being held by a support, the support has a stretch strength of less than 2,000 g/50 mm when the support is stretched by 50% longitudinal extension; and the support comprises a biaxially-oriented stretch cloth, the organic acid is isostearic acid, which is present in the plaster in an amount of 0.9 mass % to 2.5 mass %, and the polyalcohol is dipropylene glycol, which is present in the plaster in an amount of 0.2 mass % to 1.5 mass % dipropylene glycol.

2. The method of claim 1, wherein the pain is muscle pain, arthritic pain, or lumbar pain.

3. The method of claim 1, wherein the non-aqueous patch is applied to the back of the individual in need thereof.

4. The method of claim 1, wherein the non-aqueous patch is applied to the individual in need thereof for up to and including 12 hours.

5. The method of claim 1, wherein the non-aqueous patch is applied to the individual in need thereof for at least 12 hours, and the area of the non-aqueous patch remaining on the skin compared to the area of the non-aqueous patch initially applied to the individual in need thereof is at least 90%.

6. The method of claim 1, wherein the non-aqueous patch is applied for at least 12 hours, and the amount of lidocaine remaining in the non-aqueous patch compared to the amount of lidocaine in the non-aqueous patch immediately prior to application to the individual in need thereof is less than 80%.

7. The method of claim 1, wherein the adhesive power of the patch is from 0.4N/width 25 mm to 5N/width 25 mm.

8. The method of claim 1, wherein the release ratio of lidocaine from the plaster is more than 6%, after 12 hours attachment to the skin.

9. The method of claim 1, wherein the amount of lidocaine is 0.1 to 1 mg/cm2 of the plaster.

10. The method of claim 1, wherein the plaster consists of lidocaine, isostearic acid and dipropylene glycol, an elastomer, a terpene resin, butylated hydroxytoluene, liquid paraffin and light anhydrous silicic acid.

11. The method of claim 10, wherein the elastomer consists of a combination of styrene isoprene and polyisobutylene.

12. The method of claim 1, wherein the lidocaine is dissolved in the dissolving agent.

13. The method of claim 10, wherein the lidocaine, the polyalcohol and the organic acid are combined prior to the addition of the elastomer, the terpene resin, the butylated hydroxytoluene, the liquid paraffin and the light anhydrous silicic acid.

14. A method of relieving muscle pain, arthritic pain, or lumbar pain in an individual in need thereof, comprising applying a non-aqueous patch to the skin of the individual in need thereof, wherein the non-aqueous patch comprises 0.5 to 7 mass % lidocaine, and a dissolving agent comprising an organic acid and a polyalcohol, wherein the lidocaine and the dissolving agent are in a plaster, the plaster being held by a support, the support has a stretch strength of less than 2,000 g/50 mm when the support is stretched by 50% longitudinal extension, the support comprises a biaxially-oriented stretch cloth, the organic acid is isostearic acid, which is present in the plaster in an amount of 0.9 mass % to 2.5 mass %, and the polyalcohol is dipropylene glycol, which is present in the plaster in an amount of 0.2 mass % to 1.5 mass % dipropylene glycol; and wherein the non-aqueous patch is applied to the individual in need thereof for at least 12 hours, and the area of the non-aqueous patch remaining on the skin compared to the area of the non-aqueous patch initially applied to the individual in need thereof is at least 90%, and the amount of lidocaine remaining in the non-aqueous patch compared to the amount of lidocaine in the non-aqueous patch immediately prior to application to the individual in need thereof is less than 80%.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.